ADC Therapeutics SA (ADCT)

1.59

-0.17 (-9.66%)

At close: Mar 03, 2025, 3:59 PM

1.62

1.57%

After-hours: Mar 03, 2025, 06:50 PM EST

ADC Therapeutics SA Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-240.05M	-155.8M	-230.03M	-246.29M	-116.48M	-123.1M	-89.86M
Depreciation & Amortization	3.27M	2.33M	2.63M	2.19M	1.65M	740K	341K
Stock-Based Compensation	13.49M	49.32M	60.48M	37.59M	1.12M	469K	980K
Other Working Capital	-8.3M	18.4M	6.16M	10.44M	-2.34M	-1.14M	-1.8M
Other Non-Cash Items	23.23M	1.07M	-24.7M	25.1M	-1.19M	-891K	36K
Deferred Income Tax	37.1M	-708K	-21.48M	327K	1.21M	935K	48K
Change in Working Capital	44.27M	-33.01M	-20.28M	12.36M	-7.88M	481K	13.51M
Operating Cash Flow	-118.69M	-136.79M	-233.38M	-168.73M	-121.58M	-121.36M	-74.94M
Capital Expenditures	-3.22M	-2.3M	-6.38M	-2.81M	-2.15M	-2.47M	-3.16M
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-210K	-297K	-19K	-100K	-36K	-92K
Investing Cash Flow	-3.22M	-2.51M	-6.67M	-2.83M	-2.25M	-2.51M	-3.25M
Debt Repayment	n/a	-2.71M	48.61M	61.75M	-1M	n/a	n/a
Common Stock Repurchased	n/a	-221K	n/a	n/a	-141K	-24K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	73.88M	-4.32M	218.78M	54K	101.61M	-24K	n/a
Financial Cash Flow	73.88M	-593K	267.39M	494.97M	100.51M	-24K	197.24M
Net Cash Flow	-47.84M	-140.1M	27.35M	323.64M	-23.26M	-123.94M	119.08M
Free Cash Flow	-121.9M	-139.09M	-239.75M	-171.54M	-123.73M	-123.83M	-78.1M